| Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells MP Martelli, I Gionfriddo, F Mezzasoma, F Milano, S Pierangeli, F Mulas, ... Blood, The Journal of the American Society of Hematology 125 (22), 3455-3465, 2015 | 160 | 2015 |
| Immunological dysregulation in multiple myeloma microenvironment A Romano, C Conticello, M Cavalli, C Vetro, A La Fauci, NL Parrinello, ... BioMed research international 2014 (1), 198539, 2014 | 141 | 2014 |
| Circulating myeloid‐derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up‐front with a risk‐adapted strategy A Romano, NL Parrinello, C Vetro, S Forte, A Chiarenza, A Figuera, ... British journal of haematology 168 (5), 689-700, 2015 | 96 | 2015 |
| Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up C Vetro, A Romano, I Amico, C Conticello, G Motta, A Figuera, ... World Journal of Gastroenterology: WJG 20 (36), 12993, 2014 | 66 | 2014 |
| Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 … A Romano, NL Parrinello, C Vetro, A Chiarenza, C Cerchione, M Ippolito, ... Annals of hematology 97, 1009-1018, 2018 | 64 | 2018 |
| Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML MP Martelli, R Rossi, A Venanzi, M Meggendorfer, VM Perriello, G Martino, ... Blood, The Journal of the American Society of Hematology 138 (25), 2696-2701, 2021 | 38 | 2021 |
| The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma A Romano, NL Parrinello, C Vetro, D Tibullo, C Giallongo, P La Cava, ... Oncotarget 7 (41), 67333, 2016 | 34 | 2016 |
| Prognostic assessment and treatment of primary gastric lymphomas: how endoscopic ultrasonography can help in tailoring patient management C Vetro, A Chiarenza, A Romano, I Amico, V Calafiore, C Di Raimondo, ... Clinical Lymphoma Myeloma and Leukemia 14 (3), 179-185, 2014 | 33 | 2014 |
| Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML I Gionfriddo, L Brunetti, F Mezzasoma, F Milano, V Cardinali, R Ranieri, ... Leukemia 35 (9), 2552-2562, 2021 | 29 | 2021 |
| Management of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study M Napolitano, L Valore, A Malato, G Saccullo, C Vetro, ME Mitra, ... Leukemia & Lymphoma 57 (1), 116-119, 2016 | 29 | 2016 |
| Rare gastrointestinal lymphomas: the endoscopic investigation C Vetro, G Bonanno, G Giulietti, A Romano, C Conticello, A Chiarenza, ... World Journal of Gastrointestinal Endoscopy 7 (10), 928, 2015 | 28 | 2015 |
| Early interim 2-(1) fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to peripheral blood lymphocyte/monocyte ratio at diagnosis in classical … A Romano, C Vetro, D Donnarumma, S Forte, M Ippolito, F Di Raimondo Haematologica 97 (6), e21, 2012 | 27 | 2012 |
| Venetoclax in relapsed/refractory acute myeloid leukemia: are supporting evidences enough? S Brancati, L Gozzo, GL Romano, C Vetro, I Dulcamare, C Maugeri, ... Cancers 14 (1), 22, 2021 | 24 | 2021 |
| Salvage therapy of multiple myeloma: the new generation drugs A Romano, C Conticello, M Cavalli, C Vetro, C Di Raimondo, V Di Martina, ... BioMed Research International 2014 (1), 456037, 2014 | 23 | 2014 |
| AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia E Todisco, C Papayannidis, N Fracchiolla, E Petracci, C Zingaretti, ... Cancer 129 (7), 992-1004, 2023 | 22 | 2023 |
| Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia A Romano, C Giallongo, P La Cava, NL Parrinello, A Chiechi, C Vetro, ... Frontiers in Pharmacology 8, 204, 2017 | 22 | 2017 |
| Immunological deregulation in classic hodgkin lymphoma A Romano, C Vetro, G Caocci, M Greco, NL Parrinello, F Di Raimondo, ... Mediterranean Journal of Hematology and Infectious Diseases 6 (1), 2014 | 22 | 2014 |
| Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL) R Di Blasi, C Cattaneo, RE Lewis, M Tumbarello, L Angelici, G Dragonetti, ... Annals of hematology 97, 791-798, 2018 | 21 | 2018 |
| Oral lesion as unusual first manifestation of multiple myeloma: case reports and review of the literature A Romano, MS Marescalco, C Liardo, L Villari, C Vetro, C Conticello, ... Case Reports in Hematology 2014 (1), 529452, 2014 | 20 | 2014 |
| Salvage therapy with pegylated liposomal doxorubicin, bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory myeloma patients A Romano, A Chiarenza, C Conticello, M Cavalli, C Vetro, C Di Raimondo, ... European journal of haematology 93 (3), 207-213, 2014 | 18 | 2014 |
